DRKS00030932已完成未知
Randomized controlled trial to evaluate a 12-week app-guided exercise intervention in patients with knee osteoarthritis (re.flex) - re.flex
Sporlastic GmbH0 个研究点目标入组 195 人开始时间: 2023年1月20日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 195
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized controlled study
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Osteoathritis symptoms are primary located at the knee joint; moderate to severe knee osteoarthrititis diagnosis by a physician (KOOS <=60 where 100 indicates no complaints at all); good German language skills (Information sheet, questionnaires, app content); Willingness to use the app to exercise; access to a device with iOS or android operating system.
排除标准
- •Scheduled elective knee joint replacement; already implanted artificial joint; osteoarthritis primarily in the hip joint or others than the knee; diffuse pain; complaints that affect physical performance in everyday life, measured by use of the PAR-Q, verified by the physician, if applicable; complaints located at the back or lower extremities that are currently treated by a medical doctor or health professional; previous surgeries, injuries or complaints that may impair the exercise intervention itself; (digital) exercise interventions similar to the intervention under study or regular structured strengthening exercises for the lower extremities more than once a week during the past 6 months.
研究者
相似试验
终止
不适用
Recovery-focused Community support to Avoid readmissions and improve Participation after Stroke (ReCAPS)StrokeACTRN12618001468213Monash University466
已完成
4 期
Visual Field Assessment With Subjects Who Receive Either Lyrica Or Sugar PillsCTRI/2009/091/000872Pfizer Limited29
进行中（未招募）
不适用
Prospective Randomized 12-Week Controlled Study of Visual Field Change in Subjects with Partial Seizures Receiving Pregabalin or PlaceboEPILEPSY WITH PARTIAL SEIZUREMedDRA version: 16.0Level: LLTClassification code 10065336Term: Partial epilepsySystem Organ Class: 100000004852EUCTR2009-014269-25-CZPfizer Inc284
进行中（未招募）
1 期
Prospective Randomized 12-Week Controlled Study of Visual Field Change in Subjects with Partial Seizures Receiving Pregabalin or PlaceboEUCTR2009-014269-25-BGPfizer Inc284
进行中（未招募）
1 期
Prospective Randomized 12-Week Controlled Study of Visual Field Change in Subjects with Partial Seizures Receiving Pregabalin or PlaceboEPILEPSY WITH PARTIAL SEIZUREMedDRA version: 14.1Level: LLTClassification code 10065336Term: Partial epilepsySystem Organ Class: 100000004852EUCTR2009-014269-25-PLPfizer Inc, 235 East 42nd Street New York, NY 10017187